Table 6.
Overview of GRS-MAP associations.
GRS | MAP test | No. SNPs in optimal GRS | R2 | Coefficient; SE | Empirical p-valuea |
---|---|---|---|---|---|
CD | IgA—MAP0210c | 23 117 | 0.79% | -144; 84 | 0.52 |
IgA—MAP2609 | 69 507 | 1.10% | -258; 112 | 0.20 | |
IgM—MAP0210c | 343 804 | 0.46% | -427; 276 | 0.66 | |
IgM—MAP2609 | 317 | 0.60% | -10; 6 | 0.56 | |
UC | IgA—MAP0210c | 34 068 | 1.09% | 248; 122 | 0.38 |
IgA—MAP2609 | 4 551 | 0.46% | 42; 28 | 0.80 | |
IgM—MAP0210c | 3 638 | 1.14% | -57; 23 | 0.23 | |
IgM—MAP2609 | 2 788 | 0.52% | -51; 33 | 0.68 |
SNP, single nucleotide polymorphism; GRS, genetic risk score; SE, standard error; CD, Crohn’s disease; UC, ulcerative colitis.
aEmpirical p-value refers to p-value after 10 000 rounds of permutation.